This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Bar-Ilan University, Geneva University Hospitals, University of Geneva. Active years: 2017-2025.
Company Filing History:
3 out of 244 
3 out of 3 
3 out of 26 
Years Active: 2017-2025
Title: Paul Bradfield: Innovator in Barbituric Acid Derivatives
Introduction
Paul Bradfield is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his work on barbituric acid derivatives. With a total of four patents to his name, Bradfield's innovations focus on addressing critical health issues.
Latest Patents
Bradfield's latest patents include novel barbituric acid derivatives, which are designed to act as leukocyte transmigration inhibitors. These compounds are particularly useful in treating inflammatory diseases, autoimmune disorders, and various types of cancer. The synthesis and application of these derivatives represent a promising advancement in therapeutic strategies aimed at blocking leukocyte transmigration, which is a key factor in the progression of several diseases.
Career Highlights
Throughout his career, Paul Bradfield has worked with prestigious institutions such as Bar-Ilan University and the University of Geneva. His research has not only contributed to the scientific community but has also paved the way for potential new treatments in the medical field.
Collaborations
Bradfield has collaborated with notable colleagues, including Arie Lev Gruzman and Tamar Getter. These partnerships have enhanced his research efforts and have been instrumental in the development of his patented innovations.
Conclusion
Paul Bradfield's work in the field of barbituric acid derivatives showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases, highlighting the importance of innovation in healthcare.